Literature DB >> 26995783

Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.

Hongyi Yang1, Yuhua Song2.   

Abstract

Death receptor 5 (DR5)-induced apoptosis that prioritizes the death of tumor cells has been proposed as one of the promising cancer therapies. In this process, oligomerized DR5 death domain (DD) binding to Fas-associated death domain (FADD) leads to FADD activating caspase-8, which marks the formation of the death-inducing signaling complex (DISC) that initiates apoptosis. DR5 DD mutations found in cancer cells have been suggested to play an important pathological role, the mechanism through which those mutants prevent the DR5-activated DISC formation is not clear yet. This study sought to provide structural and molecular insight for the roles of four selected DR5 DD mutations (E355K, E367K, K415N, and L363F) in the oligomerization of DR5 DD-FADD complex during the DISC formation. Results from the molecular dynamics simulations show that the simulated mutants induce conformational, dynamical motions and interactions changes in the DR5 DD-FADD tetramer complex, including changes in a protein's backbone flexibility, less exposure of FADD DED's caspase-8 binding site, reduced H-bonding and hydrophobic contacts at the DR5 DD-FADD DD binding, altered distribution of the electrostatic potentials and correlated motions of residues, and reduced binding affinity of DR5 DD binding to FADD. This study provides structural and molecular insight for the influence of DR5 DD mutations on oligomerization of DR5 DD-FADD complex, which is expected to foster understanding of the DR5 DD mutants' resistance mechanism against DR5-activated DISC formation.

Entities:  

Keywords:  DISC; DR5 death domain mutations; DR5 death domain – FADD complex oligomerization; Molecular dynamics simulations

Mesh:

Substances:

Year:  2016        PMID: 26995783     DOI: 10.1007/s00894-016-2941-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  84 in total

1.  The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis.

Authors:  H Blanchard; L Kodandapani; P R Mittl; S D Marco; J F Krebs; J C Wu; K J Tomaselli; M G Grütter
Journal:  Structure       Date:  1999-09-15       Impact factor: 5.006

2.  Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.

Authors:  J Mongkolsapaya; J M Grimes; N Chen; X N Xu; D I Stuart; E Y Jones; G R Screaton
Journal:  Nat Struct Biol       Date:  1999-11

3.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

4.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

5.  Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers.

Authors:  M S Shin; H S Kim; S H Lee; W S Park; S Y Kim; J Y Park; J H Lee; S K Lee; S N Lee; S S Jung; J Y Han; H Kim; J Y Lee; N J Yoo
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

Review 6.  Caspase functions in cell death and disease.

Authors:  David R McIlwain; Thorsten Berger; Tak W Mak
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

7.  Structural insight for the roles of fas death domain binding to FADD and oligomerization degree of the Fas-FADD complex in the death-inducing signaling complex formation: a computational study.

Authors:  Qi Yan; Jay M McDonald; Tong Zhou; Yuhua Song
Journal:  Proteins       Date:  2012-11-05

8.  Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody.

Authors:  Anil Shanker; Alan David Brooks; Carlos Alberto Tristan; John William Wine; Peter John Elliott; Hideo Yagita; Kazuyoshi Takeda; Mark John Smyth; William Joseph Murphy; Thomas Joseph Sayers
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

Review 9.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  The Fas-FADD death domain complex structure unravels signalling by receptor clustering.

Authors:  Fiona L Scott; Boguslaw Stec; Cristina Pop; Małgorzata K Dobaczewska; JeongEun J Lee; Edward Monosov; Howard Robinson; Guy S Salvesen; Robert Schwarzenbacher; Stefan J Riedl
Journal:  Nature       Date:  2008-12-31       Impact factor: 49.962

View more
  6 in total

1.  Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.

Authors:  Romone M Fancy; Harrison Kim; Tong Zhou; Kurt R Zinn; Donald J Buchsbaum; Yuhua Song
Journal:  J Cell Biochem       Date:  2017-04-12       Impact factor: 4.429

2.  Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.

Authors:  Romone M Fancy; Harrison Kim; Tiara Napier; Donald J Buchsbaum; Kurt R Zinn; Yuhua Song
Journal:  J Cell Biochem       Date:  2018-04-16       Impact factor: 4.429

3.  Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study.

Authors:  Yuwei Song; Shariq Qayyum; Rory A Greer; Radomir M Slominski; Chander Raman; Andrzej T Slominski; Yuhua Song
Journal:  J Biomol Struct Dyn       Date:  2021-08-20       Impact factor: 5.235

Review 4.  The Janus Face of Death Receptor Signaling during Tumor Immunoediting.

Authors:  Eimear O' Reilly; Andrea Tirincsi; Susan E Logue; Eva Szegezdi
Journal:  Front Immunol       Date:  2016-10-31       Impact factor: 7.561

5.  Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction.

Authors:  Yingxiao Cao; Shiqi Kong; Yuling Xin; Yan Meng; Shuling Shang; Yanhui Qi
Journal:  J Cell Mol Med       Date:  2020-05-22       Impact factor: 5.310

6.  Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs).

Authors:  Andrzej T Slominski; Tae-Kang Kim; Shariq Qayyum; Yuwei Song; Zorica Janjetovic; Allen S W Oak; Radomir M Slominski; Chander Raman; Joanna Stefan; Carlos A Mier-Aguilar; Venkatram Atigadda; David K Crossman; Andriy Golub; Yaroslav Bilokin; Edith K Y Tang; Jake Y Chen; Robert C Tuckey; Anton M Jetten; Yuhua Song
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.